The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

Addressing the silent killer: How Iowans can reduce their risk for heart disease and live heart-healthy lives ...

Emilia Pérez” star and Oscar nominee Karla Sofía Gascón has issued an apology after her social media posts expressing ...